Leonteq Securities’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$398K Buy
+20,000
New +$427K 0.02% 370
2023
Q4
– Sell
-400
Closed -$26.9K – 1244
2023
Q3
$26.9K Hold
400
– – ﹤0.01% 908
2023
Q2
$27.6K Sell
400
-750
-65% -$49K ﹤0.01% 925
2023
Q1
$55.5K Sell
1,150
-745
-39% -$36.4K ﹤0.01% 781
2022
Q4
$94.6K Sell
1,895
-1,062
-36% -$51.5K ﹤0.01% 677
2022
Q3
$121K Sell
2,957
-293
-9% -$13.8K ﹤0.01% 613
2022
Q2
$179K Sell
3,250
-448
-12% -$18.9K 0.01% 574
2022
Q1
$134K Sell
3,698
-3,268
-47% -$129K ﹤0.01% 672
2021
Q4
$325K Buy
+6,966
New +$353K 0.01% 534

Other funds holding LEGN

Leonteq Securities's LEGN Position: Q3 2026 in Review

Leonteq Securities opened a new position in Legend Biotech (LEGN) in Q3 2026: 20,000 shares worth $398K. The stake represents 0.02% of the portfolio and ranks #370 among its holdings. This is a return to the name: Leonteq Securities previously reported a position in LEGN as recently as Q3 2023.

Leonteq Securities first reported a position in LEGN in Q4 2021 and has held it in 9 quarters since. 197 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Leonteq Securities held 20,000 shares of Legend Biotech worth $398K as of Q3 2026.
  • Legend Biotech was a new Leonteq Securities position in Q3 2026.
  • Legend Biotech made up 0.02% of Leonteq Securities's portfolio in Q3 2026, its #370 holding.
  • Leonteq Securities first reported a position in Legend Biotech in Q4 2021 and has held it in 9 quarters since.
  • 197 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.